|
|
.
NPI Detail
NPI: 1427063270
Type: Organization
Taxonomy Code: 261QE0700X
End-Stage Renal Disease Facility
Ambulatory Health Care Facilities/End-Stage Renal Disease (ESRD) Treatment
234 X 149XX XX
BRONX, NY 104515504
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1427063270*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXX
|
$XXXX
|
| 85027
|
COMPLETE CBC AUTOMATED
|
XXXX
|
$XXXX.XX
|
| 82948
|
REAGENT STRIP/BLOOD GLUCOSE
|
XXXX
|
$XXXX.XX
|
| 80048
|
METABOLIC PANEL TOTAL CA
|
XXXX
|
$XXXX.XX
|
| 96127
|
BRIEF EMOTIONAL/BEHAV ASSMT
|
XXXX
|
$XXX.XX
|
| 90999
|
UNLISTED DIALYSIS PROCEDURE
|
XXXX
|
$XXXXXX.XX
|
| 99283
|
EMERGENCY DEPT VISIT LOW MDM
|
XXX
|
$XXXXXX.XX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1756
|
Iron sucrose injection
|
XXXXX
|
-
|
| J0882
|
Darbepoetin alfa, esrd use
|
XXXXX
|
$XXXX.XX
|
| J0606
|
Inj, etelcalcetide, 0.1 mg
|
XXXXX
|
-
|
| J0401
|
Inj aripiprazole ext rel 1mg
|
XXXXX
|
$XXXXX.XX
|
| J9299
|
Injection, nivolumab
|
XXXX
|
$XXXXXX.XX
|
| J7512
|
Prednisone ir or dr oral 1mg
|
XXXX
|
-
|
| J2426
|
Inj, invega sustenna, 1 mg
|
XXXX
|
$XXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXX
|
-
|
| J1453
|
Fosaprepitant injection
|
XXXX
|
$XXX.XX
|
| J1642
|
Inj heparin sodium per 10 u
|
XXXX
|
-
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXX
|
$XXXXX.XX
|
| J2315
|
Naltrexone, depot form
|
XXXX
|
$XXXX.XX
|
| J9354
|
Inj, ado-trastuzumab emt 1mg
|
XXXX
|
$XXXXX.XX
|
| J2501
|
Paricalcitol
|
XXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXX
|
-
|
| J1644
|
Inj heparin sodium per 1000u
|
XXXX
|
-
|
| J1270
|
Injection, doxercalciferol
|
XXXX
|
-
|
| J1953
|
Levetiracetam injection
|
XXXX
|
-
|
| J9271
|
Inj pembrolizumab
|
XXXX
|
$XXXXX.XX
|
| J2794
|
Inj risperdal consta, 0.5 mg
|
XXXX
|
$XXXX.XX
|
| J9355
|
Inj trastuzumab excl biosimi
|
XXXX
|
$XXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXX
|
$XXXX.XX
|
| J1050
|
Medroxyprogesterone acetate
|
XXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXX
|
$XXXXXX.XX
|
| U0003
|
Cov-19 amp prb hgh thruput
|
XXXX
|
$XXXXX.XX
|
| G0378
|
Hospital observation per hr
|
XXXX
|
-
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
